David Kerr
Oprichter bij Oxford Cancer Biomarkers Ltd.
Oorsprong van het eerstegraads netwerk van David Kerr
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Oxford
87
| College/University | Other Consumer Services | 87 |
Ingenox Therapeutics Ltd.
 Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue.
7
| Private Company | Hospital/Nursing Management | 7 |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.
6
| Holding Company | Hospital/Nursing Management | 6 |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands.
4
| Private Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Kerr via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Cambridge | College/University | Director/Board Member Doctorate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder Chairman Director/Board Member | |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal President | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman Chief Tech/Sci/R&D Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Sydney | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Rhodes Trust | Director/Board Member Director/Board Member | ||
| THERMOGENESIS HOLDINGS, INC. | Medical Specialties | Chief Operating Officer Director/Board Member | |
The Oxford Health Alliance
 The Oxford Health Alliance Miscellaneous Commercial ServicesCommercial Services The Oxford Health Alliance is a British charitable company that focuses on preventing chronic diseases. The non-profit company is based in Greater London, UK. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Oxford University Hospitals NHS Trust | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Magdalen College School Oxford Ltd | College/University | Undergraduate Degree Undergraduate Degree | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
The George Institute for Global Health
 The George Institute for Global Health Miscellaneous Commercial ServicesCommercial Services The George Institute for Global Health provides research and development for international health. It develops tools to empower people to improve their own health. The firm also uses mobile technology to make healthcare accessible worldwide and improves outcomes among stroke survivors. It helps preventing complications of diabetes. The company was founded by Stephen MacMahon and Robyn Norton in 1999 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Founder Founder | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Prince's Trust
 The Prince's Trust Services to the Health IndustryHealth Services The Prince's Trust operates as a non-profit charity to help people and start up businesses. The firm addresses youth unemployment by giving practical and financial support to the young people who need it most. The company was founded in 1976 and is headquartered in London, the United Kingdom. | Services to the Health Industry | Chairman Director/Board Member | |
| University of London | College/University | Undergraduate Degree Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Graduate Degree | |
| British Society for Gene & Stem Cell Therapy | President Founder | ||
| VODAFONE GROUP PLC | Wireless Telecommunications | Director/Board Member Sales & Marketing | |
Elastagen Pty Ltd.
 Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
| DIAGEO PLC | Beverages: Alcoholic | Director/Board Member Corporate Officer/Principal | |
| INSEAD | College/University | Director/Board Member Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Nuffield College | College/University | Graduate Degree Doctorate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
Perspectum Ltd.
 Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Medical/Nursing Services | Founder Founder | |
| Bank of England | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| Saïd Business School | College/University | Corporate Officer/Principal Director/Board Member | |
| Guanghua School of Management | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
OrganOx Ltd.
 OrganOx Ltd. Electronic Equipment/InstrumentsElectronic Technology OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Founder | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Director/Board Member Founder | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Founder | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder | |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investment Managers | Chairman Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Royal Society | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder |
Statistieken
Internationaal
| Verenigd Koninkrijk | 32 |
| Verenigde Staten | 13 |
| Australië | 3 |
| Japan | 2 |
| Zwitserland | 2 |
Sectoraal
| Consumer Services | 16 |
| Health Technology | 15 |
| Commercial Services | 7 |
| Finance | 4 |
| Miscellaneous | 3 |
Operationeel
| Director/Board Member | 578 |
| Corporate Officer/Principal | 260 |
| Chairman | 129 |
| Independent Dir/Board Member | 113 |
| Founder | 88 |
Sterkste connecties
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Raj Bhikhu Parekh | 50 |
| Tiong Lu Koh | 42 |
| James Noble | 39 |
| Peter Thompson | 39 |
| Robert Charles Wigley | 39 |
| Declan Doogan | 28 |
| Len Blavatnik | 28 |
| John Bell | 27 |
| Wendy Becker | 26 |
| Patrick Pichette | 26 |
| Patrick Thomas | 24 |
| William Castell | 22 |
| Crispin Davis | 20 |
| Matthew Frohn | 20 |
- Beurs
- Insiders
- David Kerr
- Bedrijfsconnecties